OTC Stock Picks Carries Hot Penny Stocks List - SWVI, FARE, ACTC, AMBS

stamford, CT -- (SBWIRE) -- 01/24/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on Hot Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.

SWINGPLANE VENTURES (OTC: SWVI) stock’s trade opened at $0.19 and its closing price was $0.290 after scoring 70.33% .The market capitalization of SWVI was 80.32 million. Total traded volume of the stock was 88.41 million shares, while the company’s average volume remained 526,376 shares.

SWVI’s day range remained $0.18 - $0.29 while its 52 week range was $0.10 - $0.31. During its last 5 trades, the stock jumped almost 93.33%. During the last 3 month it rose 93.33%. Its year to date performance remained progressive with 26.09%.

SWINGPLANE VENTURES has changed the assignment agreement related to the acquisition of certain mining concessions in Chile. According to new terms and conditions of the agreement, the company will will obtain all of the issued and outstanding shares of Mid Americas Corp.

Will SWVI Continue To Move Higher? Find Out Here

Net Profits Ten Inc (OTC:FARE) remained among the day gainers and traded with volume of 56.02 million shares in the last session, as compared to average volume of 34.39 million shares.

Previous 5 days graph demonstrated an optimistic move of 28.5%. FARE’s quarterly performance remained in the red with the percentage of -27.27, while its year to date performance showed that the stock plunged overall -37.55%.

The 52 week range of the stock remained $0.03 - $2.50, while its lowest price for the day was $0.06 and its hit its highest price at $0.11. FARE’s total market capitalization is $22.46million.

How Should Investors Trade FARE Now? Don’t Miss out a Special Trend Analysis

Advanced Cell Technology, Inc. (OTC:ACTC) is a biotechnology company applying cellular technology in the field of regenerative medicine. It started its trading session with the price $0.09 and closed at $0.0815 by decreasing -4.23%.

ACTC was a gainer in the 5 days activity and jumped about 0.37%. The one month performance of the stock was positive and it scored more than 38.14%.

ACTC’s stocks traded with total volume of 17.40 million shares, while the average trading capacity remained 13.37 million shares. The beta of ACTC stands at -2.01. Day range of the stock was $0.08 -$0.09.

Why Should Investors Buy ACTC After the Recent Fall? Just Go Here and Find Out

AMARANTUS BIOSCI INC (OTC:AMBS) opened at the price of $0.10 and its closing price was $0.100 after gaining 3.63% for the day. The company traded with the total volume of 10.63 million shares, while its average trading volume remained 21.16 million shares.

During the last one month, it rose with the percentage of 31.58%. Its year to date performance remained adverse -24.24%.

The 52-week high price of the stock remained $0.19, while during last trade, its minimum price was $0.08 and it gained its highest price of $0.10.

What was the Moving Force behind AMBS' Bullish Run? Read This Research Report

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks, via technical analysis and fundamentals and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.